ObsEva SA
OBSVDelisted Mar 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001685316
ObsEva SA was delisted on Mar 27, 2023; its insiders filed their last Form 4 on Apr 11, 2023; 27 institutions reported holding it in 13F filings for Q4 2022, worth $1.89M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by ObsEva SA insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for ObsEva SA, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Loumaye Ernest | Director | 10,000,000 | Apr 11, 2023 | 0 |
| Brown William Michael | Interim CEO and CFO | – | Feb 24, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2023 (view filing)4:02 PM ET | Apr 6 | 5 daysLate | Loumaye ErnestDirector | PPurchase | +4.00M | $0.095 | +$380.0K | +66.7%10.0M after | |
| Mar 2, 2023 (view filing)4:16 PM ET | Feb 28 | 2 days | Loumaye ErnestDirector | PPurchase | +4.00M | $0.11 | +$440.0K | +200.0%6.00M after |